首页> 外国专利> Novel chelating agents and conjugates thereof, their synthesis and use as diagnois and therapeutic agents

Novel chelating agents and conjugates thereof, their synthesis and use as diagnois and therapeutic agents

机译:新型螯合剂及其缀合物,其合成及用作诊断和治疗剂

摘要

The present invention relates to novel bifunctional chelates that are based on asymmetrical cyclen derivatives. The chelates contain either three acetates and one methylphosphonic arm or three acetates and one methylphosphonic arm enabling to link the chelate through P-alkyl within phosphoric acid derivative or through PO-alkyl within phosphonic derivative to any organic back-bone suited for targeting. Suitable targeting moieties are monoclonal antibodies, their fragments and recombinant derivatives such as single chain antibodies, diabodies, triabodies, humanized, human or chimeric variants but also peptides, aptamers, spiegelmers, nucleotides, anti sense oligomers and conventional small molecules. These novel bifunctional chelates are suited for the production of kits for the routine labelling of targeting moieties to be used in radiotherapy with radiometals such as Yttrium-90, or for Magnetic Resonance Imagining (MRI) using Gadolinium.
机译:本发明涉及基于不对称环素衍生物的新型双功能螯合物。螯合物包含三种乙酸酯和一个甲基膦酸酯臂或三种乙酸酯和一个甲基膦酸酯臂,它们能够使螯合物通过磷酸衍生物中的P-烷基或通过膦酸衍生物中的PO-烷基与任何适合靶向​​的有机骨架相连。合适的靶向部分是单克隆抗体,其片段和重组衍生物,例如单链抗体,双抗体,三抗体,人源化的,人或嵌合的变体,还有肽,适体,镜像异构体,核苷酸,反义寡聚体和常规的小分子。这些新型的双功能螯合物适合用于试剂盒的常规标记试剂盒的生产,该试剂盒可用于放射性金属如Yttrium-90的放射治疗,或使用Ga的磁共振成像(MRI)。

著录项

  • 公开/公告号US2004167330A1

    专利类型

  • 公开/公告日2004-08-26

    原文格式PDF

  • 申请/专利权人 LUKES IVAN;HERMANN PETR;

    申请/专利号US20040484391

  • 发明设计人 IVAN LUKES;PETR HERMANN;

    申请日2004-01-20

  • 分类号C07D257/02;

  • 国家 US

  • 入库时间 2022-08-21 23:21:57

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号